ANRO logo

Alto Neuroscience (ANRO) EBITDA

Annual EBITDA

-$34.56 M
-$7.19 M-26.29%

December 31, 2023


Summary


Performance

ANRO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANROprofitabilitymetrics:

Quarterly EBITDA

-$16.31 M
-$742.00 K-4.77%

September 30, 2024


Summary


Performance

ANRO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANROprofitabilitymetrics:

TTM EBITDA

-$55.60 M
-$7.60 M-15.82%

September 30, 2024


Summary


Performance

ANRO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANROprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ANRO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-26.3%0.0%0.0%
3 y3 years-286.7%-137.3%-285.4%
5 y5 years-286.7%-137.3%-285.4%

ANRO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-286.7%at low-137.3%at low-636.0%at low
5 y5-year-286.7%at low-137.3%at low-636.0%at low
alltimeall time-286.7%at low-137.3%at low-636.0%at low

Alto Neuroscience EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$16.31 M(+4.8%)
-$55.60 M(+15.8%)
Jun 2024
-
-$15.57 M(+20.0%)
-$48.01 M(+18.1%)
Mar 2024
-
-$12.97 M(+20.7%)
-$40.66 M(+17.6%)
Dec 2023
-$34.56 M
-$10.75 M(+23.3%)
-$34.56 M(+10.2%)
Sep 2023
-
-$8.71 M(+6.0%)
-$31.37 M(+38.5%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$8.22 M(+19.6%)
-$22.65 M(+57.0%)
Mar 2023
-
-$6.87 M(-9.0%)
-$14.43 M(+91.0%)
Dec 2022
-$27.37 M(+206.2%)
-
-
Dec 2022
-
-$7.55 M
-$7.55 M
Dec 2021
-$8.94 M
-
-

FAQ

  • What is Alto Neuroscience annual EBITDA?
  • What is the all time high annual EBITDA for Alto Neuroscience?
  • What is Alto Neuroscience annual EBITDA year-on-year change?
  • What is Alto Neuroscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Alto Neuroscience?
  • What is Alto Neuroscience quarterly EBITDA year-on-year change?
  • What is Alto Neuroscience TTM EBITDA?
  • What is the all time high TTM EBITDA for Alto Neuroscience?
  • What is Alto Neuroscience TTM EBITDA year-on-year change?

What is Alto Neuroscience annual EBITDA?

The current annual EBITDA of ANRO is -$34.56 M

What is the all time high annual EBITDA for Alto Neuroscience?

Alto Neuroscience all-time high annual EBITDA is -$8.94 M

What is Alto Neuroscience annual EBITDA year-on-year change?

Over the past year, ANRO annual EBITDA has changed by -$7.19 M (-26.29%)

What is Alto Neuroscience quarterly EBITDA?

The current quarterly EBITDA of ANRO is -$16.31 M

What is the all time high quarterly EBITDA for Alto Neuroscience?

Alto Neuroscience all-time high quarterly EBITDA is -$6.87 M

What is Alto Neuroscience quarterly EBITDA year-on-year change?

Over the past year, ANRO quarterly EBITDA has changed by $0.00 (0.00%)

What is Alto Neuroscience TTM EBITDA?

The current TTM EBITDA of ANRO is -$55.60 M

What is the all time high TTM EBITDA for Alto Neuroscience?

Alto Neuroscience all-time high TTM EBITDA is -$7.55 M

What is Alto Neuroscience TTM EBITDA year-on-year change?

Over the past year, ANRO TTM EBITDA has changed by $0.00 (0.00%)